Roxane S Burkett

Roxane S. Burkett serves as the primary contracting lead for the National Human Genome Research Institute (NHGRI), where she oversees the acquisition of advanced genomic technologies and research infrastructure critical to advancing precision medicine and high-throughput sequencing capabilities. Her role is central to executing NHGRI’s mission of translating genomic discoveries into clinical and public health applications, managing complex procurements for cutting-edge analytical instruments, bioinformatics platforms, and translational research services. She specializes in sole-source and competitive acquisitions under the Federal Acquisition Regulation, ensuring alignment with NIH scientific priorities and regulatory compliance. Burkett maintains strategic relationships with leading providers in genomic science, including Illumina, Inc., Translational Genomics Research Institute, and Government Scientific Source Inc., partnering with vendors that deliver specialized sequencing systems, genomic data analysis tools, and laboratory automation solutions. Her procurement patterns reflect a preference for established scientific suppliers with proven technical expertise in next-generation sequencing and bioinformatics, often engaging through performance-based contracts that emphasize innovation, scalability, and data interoperability. Her contracting activity is exclusively non-set-aside, reflecting the highly specialized nature of NHGRI’s requirements and the limited pool of vendors capable of meeting rigorous scientific and technical standards. While socioeconomic set-asides are not utilized, her approach ensures rigorous evaluation of vendor capabilities to maintain scientific integrity and mission readiness. Burkett’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 541715 (Research and Development in the Physical, Engineering, and Life Sciences), where she acquires next-generation sequencers, mass spectrometers, computational pipelines, and custom bioinformatics services. Her expertise centers on procuring high-complexity, mission-critical scientific equipment and R&D services that underpin NHGRI’s leadership in genomic innovation.